Refractiv Revenue and Competitors
Estimated Revenue & Valuation
- Refractiv's estimated annual revenue is currently $1M per year.
- Refractiv's estimated revenue per employee is $87,000
Employee Data
- Refractiv has 12 Employees.
Refractiv's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Operations at Refractiv | Reveal Email/Phone |
2 | Credit Controller | Reveal Email/Phone |
3 | Marketing Executive | Reveal Email/Phone |
Refractiv Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $849.4M | 4243 | 1% | $985.9M | $1.8B |
#2 | $1220M | 247 | -44% | $58.5M | $7.9B |
#3 | $748.9M | 1664 | 4% | $578.5M | $4.1B |
#4 | $46.9M | 294 | N/A | N/A | N/A |
#5 | $2M | 20 | N/A | N/A | N/A |
#6 | $89.3M | 502 | 0% | $17.5M | N/A |
#7 | $2.4M | 24 | N/A | N/A | N/A |
#8 | $7M | 54 | 10% | N/A | N/A |
#9 | $27M | 175 | -12% | N/A | N/A |
#10 | $0.3M | 4 | N/A | N/A | N/A |
#11 | $1.3M | 15 | N/A | N/A | N/A |
#12 | $0.6M | 8 | N/A | N/A | N/A |
#13 | $2.7M | 27 | N/A | N/A | N/A |
#14 | $0.4M | 6 | N/A | N/A | N/A |
#15 | $0.5M | 7 | N/A | N/A | N/A |
#16 | $12.9M | 92 | N/A | N/A | N/A |
#17 | $83.4M | 453 | 8% | $11M | N/A |
#18 | $2.6M | 18 | N/A | N/A | N/A |
#19 | $36.5M | 237 | N/A | N/A | N/A |
#20 | $8.4M | 42 | N/A | N/A | N/A |
What Is Refractiv?
N/A
Total Funding
12
Number of Employees
$1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Refractiv News
2022-04-20 - Oyster Point Pharma to Present New Clinical Data at the American Society of
Cataract and Refractive Surge
In October 2021, Oyster Point Pharma received FDA-approval for TYRVAYA® (varenicline solution) Nasal Spray for the treatment of the signs and...
2022-04-19 - Bausch + Lomb Will Present New Scientific Data During the American Society
of Cataract and Refractive Sur
10 Podium Presentations, Two Posters Include Results from the First Pivotal Phase 3 Trial of Investigational Treatment NOV03...
2022-04-17 - Ocular Therapeutix to Present Clinical Data at the 2022 American Society
of Cataract and Refractive Surg
"The data we are presenting includes updates on DEXTENZA, which is commercially available to treat inflammation and pain associated ophthalmic...
Other Companies in Leeds
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | -52% | N/A |
#2 | $0.6M | 12 | 9% | N/A |
#3 | N/A | 13 | 44% | N/A |
#4 | N/A | 13 | 8% | N/A |
#5 | $1M | 13 | -24% | N/A |